Feds Cut Number of MN Clinics that Got NECC Drugs

The federal government now says 111 Minnesota clinics received drugs from a Massachusetts pharmacy at the center of a fungal meningitis outbreak. That's 18 fewer clinics than state officials reported last week after receiving a different provider list, and they don't know why the number changed.
    
Only one steroid made by New England Compounding Center has been linked to the fungal meningitis outbreak. But the Food and Drug Administration warns it can't verify the safety of other drugs made at the facility.
    
Assistant State Epidemiologist Richard Danila tells Minnesota Public Radio the lower number of clinics is confusing.
    
A spokeswoman says the FDA is focusing on drugs shipped since May 21, believed to be at greatest risk of contamination.
    
Minnesota has nine confirmed cases of fungal meningitis so far.
    
NECC customer list sorted by state
    
NECC customer list sorted by customer with product information

(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Tweet

Related Stories:

• Mass. Firm in Meningitis Case Eyes Bankruptcy Help
• Minn. Records 13th Illness from Tainted Steroids
• Senate Health Chair Wants New Drug Compound Rules
• Owner of Meningitis-Linked Pharmacy Takes Fifth
• Ham Lake Woman Sues After Contracting Meningitis
• Lawmakers Issue Subpoena for Pharmacy Director
• FDA Chief Will Testify at First Meningitis Hearing
• Tests Find Bacteria in Products of Mass. Pharmacy
• Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
• Mass. Firm Tied to Closed Pharmacy Issues Recall